RA0248

antibody from Oursmab
Targeting: SCGB1A1 CC10, CC16, CCSP, UGB
Provider product page for RA0248

Antibody data

Product number
RA0248 - Provider product page
Provider
Oursmab
Product name
Freneslerbart (Biosimilar Reference Antibody) (Fel d 1)
Antibody type
Monoclonal
Description
Freneslerbart is an investigational, immunoglobulin G4 kappa (IgG4¦Ê) monoclonal antibody developed for the treatment or prevention of allergic reactions to cats. It functions as a targeted allergen-neutralizing therapy. Freneslerbart is designed to specifically bind with high affinity to Fel d 1 (Felis domesticus allergen 1), the major allergenic protein found in cat saliva, dander, and sebaceous glands. By binding to and neutralizing Fel d 1 in the environment (e.g., on airborne particles) or potentially within the body, the antibody aims to prevent the allergen from interacting with allergen-specific immunoglobulin E (IgE) on mast cells and basophils. This blockade inhibits the subsequent degranulation and release of inflammatory mediators (like histamine) that cause allergic symptoms, such as rhinitis, conjunctivitis, and asthma.
Reactivity
Human
Isotype
IgG
Vial size
100 ¦Ìg,1 mg,5 mg-500,10 mg,25 mg,50 mg,146 mg
Concentration
Bottled at the concentration indicated on the vial.
Storage
Store at -20¡ãC or -80¡ãC. Avoid repeated freeze.
SCGB1A1 protein structure - RA0248 shown in red.